{"transactions":[{"id":1486109,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:00:10.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024."}],"balance_after":150000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-070564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024070564/ownership.xml","form_type":"4"}},{"id":1585940,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T21:00:14.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024."}],"balance_after":300000,"derivative":{"exercise_price":1.94,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950170-24-028611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024028611/ownership.xml","form_type":"4"}},{"id":1793861,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2023-08-29T20:08:25.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":2.76,"value":11040.0,"ownership":{"direct":true},"balance_after":135638,"source":{"system":"sec-edgar","filing":"0001209191-23-047575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123047575/doc4.xml","form_type":"4"}},{"id":1823398,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-25T16:25:14.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":124125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023."}],"balance_after":124125,"derivative":{"exercise_price":4.2,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":124125},"source":{"system":"sec-edgar","filing":"0001209191-23-043273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123043273/doc4.xml","form_type":"4"}},{"id":2002815,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-21T22:01:19.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":125500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023."}],"balance_after":125500,"derivative":{"exercise_price":3.21,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":125500},"source":{"system":"sec-edgar","filing":"0001209191-23-011255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123011255/doc4.xml","form_type":"4"}},{"id":2307105,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T21:31:40.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":16668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on March 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning on March 31, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16668},"source":{"system":"sec-edgar","filing":"0001209191-22-022578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122022578/doc4.xml","form_type":"4"}},{"id":2307104,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2022-04-04T21:31:40.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":7068,"price":4.88,"value":34491.84,"ownership":{"direct":true},"balance_after":103638,"source":{"system":"sec-edgar","filing":"0001209191-22-022578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122022578/doc4.xml","form_type":"4"}},{"id":2307103,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2022-04-04T21:31:40.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":16668,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award"},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award"}],"balance_after":110706,"source":{"system":"sec-edgar","filing":"0001209191-22-022578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122022578/doc4.xml","form_type":"4"}},{"id":2314897,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-29T20:15:02.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":21333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022."}],"balance_after":21333,"derivative":{"exercise_price":5.01,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":21333},"source":{"system":"sec-edgar","filing":"0001209191-22-021458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122021458/doc4.xml","form_type":"4"}},{"id":2314896,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-29T20:15:02.000Z","date":"2022-02-09","kind":"grant","acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022."}],"balance_after":82000,"derivative":{"exercise_price":6.91,"expiration_date":"2032-02-08","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001209191-22-021458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919122021458/doc4.xml","form_type":"4"}},{"id":2506257,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-17T22:00:21.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in eight equal semi-annual installments beginning November 14, 2018."}],"balance_after":10000,"derivative":{"exercise_price":8.26,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-21-045069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321045069/doc4.xml","form_type":"4"}},{"id":2506256,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2021-11-17T22:00:21.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":8000,"price":18.05,"value":144400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.21, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":94038,"source":{"system":"sec-edgar","filing":"0000899243-21-045069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321045069/doc4.xml","form_type":"4"}},{"id":2506255,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2021-11-17T22:00:21.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":8000,"price":8.26,"value":66080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."}],"balance_after":102038,"source":{"system":"sec-edgar","filing":"0000899243-21-045069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321045069/doc4.xml","form_type":"4"}},{"id":2512225,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-15T22:00:23.000Z","date":"2021-11-11","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":105000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-21-044603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321044603/doc4.xml","form_type":"4"}},{"id":2512224,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2021-11-15T22:00:23.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":20000,"price":15.0677,"value":301354.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.29, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":94038,"source":{"system":"sec-edgar","filing":"0000899243-21-044603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321044603/doc4.xml","form_type":"4"}},{"id":2512223,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2021-11-15T22:00:23.000Z","date":"2021-11-11","kind":"exercise","acquired":true,"shares":20000,"price":6.42,"value":128400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021."}],"balance_after":114038,"source":{"system":"sec-edgar","filing":"0000899243-21-044603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321044603/doc4.xml","form_type":"4"}},{"id":2545216,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Restricted Stock Units","published_at":"2021-10-08T20:00:14.000Z","date":"2021-10-03","kind":"exercise","acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001209191-21-060021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121060021/doc4.xml","form_type":"4"}},{"id":2545215,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2021-10-08T20:00:14.000Z","date":"2021-10-06","kind":"tax_withholding","acquired":false,"shares":14134,"price":12.97,"value":183317.98,"ownership":{"direct":true},"balance_after":94038,"source":{"system":"sec-edgar","filing":"0001209191-21-060021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121060021/doc4.xml","form_type":"4"}},{"id":2545214,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2021-10-08T20:00:14.000Z","date":"2021-10-03","kind":"exercise","acquired":true,"shares":33334,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."}],"balance_after":108172,"source":{"system":"sec-edgar","filing":"0001209191-21-060021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121060021/doc4.xml","form_type":"4"}},{"id":2558547,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-27T20:30:20.000Z","date":"2021-09-23","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":125000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-057785","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121057785/doc4.xml","form_type":"4"}},{"id":2558546,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2021-09-27T20:30:20.000Z","date":"2021-09-23","kind":"sale","acquired":false,"shares":20000,"price":15.2323,"value":304646.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.58, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":74838,"source":{"system":"sec-edgar","filing":"0001209191-21-057785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121057785/doc4.xml","form_type":"4"}},{"id":2558545,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CSO"}}],"security":"Common Stock","published_at":"2021-09-27T20:30:20.000Z","date":"2021-09-23","kind":"exercise","acquired":true,"shares":20000,"price":6.42,"value":128400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."}],"balance_after":94838,"source":{"system":"sec-edgar","filing":"0001209191-21-057785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919121057785/doc4.xml","form_type":"4"}},{"id":2862318,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T22:49:03.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021."}],"balance_after":75000,"derivative":{"exercise_price":15.55,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-21-006360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924321006360/doc4.xml","form_type":"4"}},{"id":3011368,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Restricted Stock Units","published_at":"2020-10-06T21:08:46.000Z","date":"2020-10-03","kind":"exercise","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 3, 2019, the reporting person was granted 100,000 restricted stock units, scheduled to vest in three equal annual installments beginning on October 3, 2019."}],"balance_after":33334,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0000899243-20-027608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924320027608/doc4.xml","form_type":"4"}},{"id":3011367,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-10-06T21:08:46.000Z","date":"2020-10-05","kind":"tax_withholding","acquired":false,"shares":9800,"price":16.3,"value":159740.0,"ownership":{"direct":true},"balance_after":58091,"source":{"system":"sec-edgar","filing":"0000899243-20-027608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924320027608/doc4.xml","form_type":"4"}},{"id":3011366,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-10-06T21:08:46.000Z","date":"2020-10-03","kind":"exercise","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock received upon vesting of a restricted stock unit award."}],"balance_after":67891,"source":{"system":"sec-edgar","filing":"0000899243-20-027608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000089924320027608/doc4.xml","form_type":"4"}},{"id":3064435,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-07T21:41:33.000Z","date":"2020-08-05","kind":"exercise","acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":145000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001209191-20-045698","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045698/doc4.xml","form_type":"4"}},{"id":3064434,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-07T21:41:33.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":800,"price":20.01,"value":16008.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."}],"balance_after":34558,"source":{"system":"sec-edgar","filing":"0001209191-20-045698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045698/doc4.xml","form_type":"4"}},{"id":3064433,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-07T21:41:33.000Z","date":"2020-08-05","kind":"exercise","acquired":true,"shares":800,"price":6.42,"value":5136.0,"ownership":{"direct":true},"balance_after":35358,"source":{"system":"sec-edgar","filing":"0001209191-20-045698","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045698/doc4.xml","form_type":"4"}},{"id":3066784,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-04","kind":"exercise","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":145800,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066783,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":146200,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066782,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning November 14, 2018."}],"balance_after":18000,"derivative":{"exercise_price":8.26,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066781,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-04","kind":"sale","acquired":false,"shares":400,"price":20.14,"value":8056.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to\n$20.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set\nforth in this footnote."}],"balance_after":34558,"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066780,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-04","kind":"exercise","acquired":true,"shares":400,"price":6.42,"value":2568.0,"ownership":{"direct":true},"balance_after":34958,"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066779,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":5800,"price":20.01,"value":116058.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020."}],"balance_after":34558,"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066778,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":3800,"price":6.42,"value":24396.0,"ownership":{"direct":true},"balance_after":40358,"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3066777,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-08-05T20:50:04.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":2000,"price":8.26,"value":16520.0,"ownership":{"direct":true},"balance_after":36558,"source":{"system":"sec-edgar","filing":"0001209191-20-045142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120045142/doc4.xml","form_type":"4"}},{"id":3178380,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Restricted Stock Units","published_at":"2020-04-10T22:25:29.000Z","date":"2020-03-31","kind":"exercise","acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020."}],"balance_after":100001,"derivative":{"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001209191-20-024164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120024164/doc4.xml","form_type":"4"}},{"id":3178379,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Restricted Stock Units","published_at":"2020-04-10T22:25:29.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents an award of restricted stock units granted on March 31, 2020 pursuant to the reporting person's employment agreement. The restricted stock units vest in three equal annual installments beginning on March 31, 2020."}],"balance_after":116667,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-024164","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120024164/doc4.xml","form_type":"4"}},{"id":3178378,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-04-10T22:25:29.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":5354,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34558,"source":{"system":"sec-edgar","filing":"0001209191-20-024164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120024164/doc4.xml","form_type":"4"}},{"id":3178377,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2020-04-10T22:25:29.000Z","date":"2020-03-31","kind":"exercise","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39912,"source":{"system":"sec-edgar","filing":"0001209191-20-024164","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120024164/doc4.xml","form_type":"4"}},{"id":3276170,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-12T21:51:33.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 5, 2020."}],"balance_after":65000,"derivative":{"exercise_price":16.26,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-008800","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919120008800/doc4.xml","form_type":"4"}},{"id":3381645,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Restricted Stock Units","published_at":"2019-11-04T22:34:18.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a restricted stock unit award granted on October 3, 2019. The restricted stock units vest in three equal annual installments beginning on October 3, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents a restricted stock unit award granted on October 3, 2019. The restricted stock units vest in three equal annual installments beginning on October 3, 2019."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Represents a restricted stock unit award granted on October 3, 2019. The restricted stock units vest in three equal annual installments beginning on October 3, 2019."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001209191-19-054991","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119054991/doc4.xml","form_type":"4"}},{"id":3381644,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2019-11-04T22:34:18.000Z","date":"2019-11-01","kind":"tax_withholding","acquired":false,"shares":12087,"price":8.63,"value":104310.81,"ownership":{"direct":true},"balance_after":23246,"source":{"system":"sec-edgar","filing":"0001209191-19-054991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119054991/doc4.xml","form_type":"4"}},{"id":3381643,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2019-11-04T22:34:18.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35333,"source":{"system":"sec-edgar","filing":"0001209191-19-054991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119054991/doc4.xml","form_type":"4"}},{"id":3396446,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Restricted Stock Units","published_at":"2019-10-07T22:12:23.000Z","date":"2019-10-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit award represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents a restricted stock unit award granted on October 3, 2019. The restricted stock units vest in three equal annual installments beginning on October 3, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents a restricted stock unit award granted on October 3, 2019. The restricted stock units vest in three equal annual installments beginning on October 3, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-052713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119052713/doc4.xml","form_type":"4"}},{"id":3396445,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2019-10-07T22:12:23.000Z","date":"2019-10-03","kind":"grant","acquired":true,"shares":400000,"price":7.53,"value":3012000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning April 3, 2020."}],"balance_after":400000,"derivative":{"exercise_price":7.53,"expiration_date":"2029-10-03","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-19-052713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119052713/doc4.xml","form_type":"4"}},{"id":3603628,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T21:16:19.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a stock option award granted on July 23, 2018 that partially vested upon the achievement of certain performance based conditions as determined by the Compensation Committee of Cue Biopharma, Inc. on March 6, 2019. As of March 6, 2019, 50,000 of these options were vested and exercisable. The remaining 50,000 will become vested and exercisable only upon the achievement of certain performance based conditions."}],"balance_after":100000,"derivative":{"exercise_price":11.54,"expiration_date":"2025-07-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-018090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119018090/doc4.xml","form_type":"4"}},{"id":3603627,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-08T21:16:19.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019."}],"balance_after":150000,"derivative":{"exercise_price":6.42,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-19-018090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919119018090/doc4.xml","form_type":"4"}},{"id":3718719,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-12-26T23:25:21.000Z","date":"2018-12-21","kind":"purchase","acquired":true,"shares":2000,"price":4.37,"value":8740.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-18-064128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118064128/doc4.xml","form_type":"4"}},{"id":3841272,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-16T20:11:13.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning November 14, 2018."}],"balance_after":20000,"derivative":{"exercise_price":8.26,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-047026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118047026/doc4.xml","form_type":"4"}},{"id":3930183,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":90136,"kind":"person","name":"Suri Anish","position":1,"cik":"0001739130","reported_name":"Suri Anish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2018-05-16T21:24:13.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options become exercisable in eight equal semi-annual installments beginning November 14, 2018."}],"balance_after":250000,"derivative":{"exercise_price":14.32,"expiration_date":"2025-05-14","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-18-030609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919118030609/doc4.xml","form_type":"4"}}]}